Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Syprine
2. Trien
3. Trientine
4. Trientine Dihydrochloride
5. Triethylenetetramine
1. Triethylenetetramine Dihydrochloride
2. 38260-01-4
3. Syprine
4. Trientine Dihydrochloride
5. Trientine Hcl
6. Mk-0681
7. 1,2-ethanediamine, N,n'-bis(2-aminoethyl)-, Dihydrochloride
8. Triethylene Tetramine Dihydrochloride
9. Teta
10. N,n'-bis(2-aminoethyl)-1,2-ethanediamine Dihydrochloride
11. Hc3nx54582
12. Nsc-759164
13. N1,n1'-(ethane-1,2-diyl)bis(ethane-1,2-diamine) Dihydrochloride
14. Trien Dihydrochloride
15. Cuprid
16. 1,2-ethanediamine,n1,n2-bis(2-aminoethyl)-, Hydrochloride (1:2)
17. Trientine Hydrochloride [usan]
18. Einecs 253-854-3
19. Mk 0681
20. N,n'-bis(2-aminoethyl)ethylenediamine Dihydrochloride
21. Laszarin
22. Metalite
23. Unii-hc3nx54582
24. Trientine-2hcl
25. 2,2'-ethylenediiminobis(ethylamine) Dihydrochloride
26. Syprine (tn)
27. Trientine Hydrochloride [usan:usp]
28. Trientinedihydrochloride
29. Triethyl Enetetramine 2hcl
30. Schembl506189
31. Chebi:9706
32. Chembl3989777
33. Dtxsid2057863
34. Amy3335
35. Tja-250
36. Mk-681
37. N'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine;dihydrochloride
38. S6585
39. Trientine Hydrochloride (jp17/usp)
40. Trientine Hydrochloride [jan]
41. Trientine Dihydrochloride [mi]
42. Akos028109579
43. Ccg-213505
44. Nsc 759164
45. Trientine Hydrochloride [vandf]
46. Trientine Hydrochloride [usp-rs]
47. Trientine Dihydrochloride [mart.]
48. Bs-49370
49. Trientine Dihydrochloride [who-dd]
50. Db-049259
51. Ft-0639448
52. Trientine Hydrochloride [orange Book]
53. D00736
54. E78246
55. Trientine Hydrochloride [usp Monograph]
56. 260t014
57. Q27279855
58. N1,n1'-(ethane-1,2-diyl)diethane-1,2-diamine Dihydrochloride
59. N\'-[2-(2-aminoethylamino)ethyl]ethane-1,2-diamine,dihydrochloride
60. Trientine Hydrochloride, United States Pharmacopeia (usp) Reference Standard
61. Triethylenetetramine Dihydrochloride, Puriss., 2xcryst., >=99.0% (at)
62. Trientine Hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Molecular Weight | 219.15 g/mol |
---|---|
Molecular Formula | C6H20Cl2N4 |
Hydrogen Bond Donor Count | 6 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 7 |
Exact Mass | 218.1065020 g/mol |
Monoisotopic Mass | 218.1065020 g/mol |
Topological Polar Surface Area | 76.1 Ų |
Heavy Atom Count | 12 |
Formal Charge | 0 |
Complexity | 49.7 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 3 |
1 of 2 | |
---|---|
Drug Name | Syprine |
PubMed Health | Trientine (By mouth) |
Drug Classes | Heavy Metal Chelator |
Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
Active Ingredient | Trientine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Aton |
2 of 2 | |
---|---|
Drug Name | Syprine |
PubMed Health | Trientine (By mouth) |
Drug Classes | Heavy Metal Chelator |
Drug Label | Trientine hydrochloride is N,N'-bis (2-aminoethyl)-1,2-ethanediamine dihydrochloride. It is a white to pale yellow crystalline hygroscopic powder. It is freely soluble in water, soluble in methanol, slightly soluble in ethanol, and insoluble in chlor |
Active Ingredient | Trientine hydrochloride |
Dosage Form | Capsule |
Route | Oral |
Strength | 250mg |
Market Status | Prescription |
Company | Aton |
Cufence is indicated for the treatment of Wilsons disease in patients intolerant to D-Penicillamine therapy, in adults and children aged 5 years or older.
Chelating Agents
Chemicals that bind to and remove ions from solutions. Many chelating agents function through the formation of COORDINATION COMPLEXES with METALS. (See all compounds classified as Chelating Agents.)
A16A
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-12-23
Pay. Date : 2016-09-13
DMF Number : 30878
Submission : 2016-11-08
Status : Active
Type : II
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm :
NDC Package Code : 58159-031
Start Marketing Date : 2024-12-09
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (35kg/35kg)
Marketing Category : BULK INGREDIENT
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Reviewed
Rev. Date : 2015-12-15
Pay. Date : 2015-09-21
DMF Number : 29019
Submission : 2015-09-25
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Reviewed
Rev. Date : 2016-03-01
Pay. Date : 2015-09-15
DMF Number : 29527
Submission : 2015-09-03
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37777
Submission : 2022-12-16
Status : Active
Type : II
GDUFA
DMF Review : Reviewed
Rev. Date : 2020-10-23
Pay. Date : 2020-06-19
DMF Number : 34910
Submission : 2020-08-28
Status : Active
Type : II
NDC Package Code : 70966-0016
Start Marketing Date : 1985-11-08
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-04-17
Pay. Date : 2017-02-22
DMF Number : 31395
Submission : 2017-02-23
Status : Active
Type : II
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm :
NDC Package Code : 14593-914
Start Marketing Date : 2023-09-25
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (15kg/15kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-09-14
Pay. Date : 2017-08-17
DMF Number : 31085
Submission : 2016-12-02
Status : Active
Type : II
Date of Issue : 2020-04-15
Valid Till : 2023-05-19
Written Confirmation Number : WC-0281new2
Address of the Firm :
NDC Package Code : 50379-0017
Start Marketing Date : 2015-10-07
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2018-09-03
Pay. Date : 2018-07-17
DMF Number : 32956
Submission : 2018-07-19
Status : Active
Type : II
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0042
Address of the Firm :
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5351
Submission : 1984-05-17
Status : Inactive
Type : II
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
GDUFA
DMF Review : Complete
Rev. Date : 2016-12-23
Pay. Date : 2016-09-13
DMF Number : 30878
Submission : 2016-11-08
Status : Active
Type : II
ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.
GDUFA
DMF Review : Complete
Rev. Date : 2015-12-15
Pay. Date : 2015-09-21
DMF Number : 29019
Submission : 2015-09-25
Status : Active
Type : II
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
GDUFA
DMF Review : Complete
Rev. Date : 2016-03-01
Pay. Date : 2015-09-15
DMF Number : 29527
Submission : 2015-09-03
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-09-18
Pay. Date : 2015-04-13
DMF Number : 29085
Submission : 2015-08-27
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-03-17
Pay. Date : 2016-09-14
DMF Number : 30905
Submission : 2016-09-15
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2015-01-21
Pay. Date : 2014-05-07
DMF Number : 12659
Submission : 1997-09-18
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-04-17
Pay. Date : 2017-02-22
DMF Number : 31395
Submission : 2017-02-23
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-09-14
Pay. Date : 2017-08-17
DMF Number : 31085
Submission : 2016-12-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 5351
Submission : 1984-05-17
Status : Inactive
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2018-09-03
Pay. Date : 2018-07-17
DMF Number : 32956
Submission : 2018-07-19
Status : Active
Type : II
Japanese Pharmacopoeia Trientine Hydrochloride
Registration Number : 218MF10740
Registrant's Address : 2-27-1 Shinkawa, Chuo-ku, Tokyo
Initial Date of Registration : 2006-09-06
Latest Date of Registration : 2006-09-06
Nuray is an expert in the synthesis of Niche novel APIs, the first to launch Generics, NCEs, Advanced Intermediates // USFDA certified.
Date of Issue : 2024-02-20
Valid Till : 2026-12-06
Written Confirmation Number : WC-0416
Address of the Firm : Plot No. 111 SIDCO Industrial Estate, Kakkalur Thiruvallur-602003 Tamil Nadu, In...
Date of Issue : 2022-09-30
Valid Till : 2025-09-08
Written Confirmation Number : WC-0369n
Address of the Firm : Plot No 1134, 1135, 1136,1137,11438, RN 1144 A & 8,1138 A & 8, Padra Jambusar Hi...
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404A2
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2020-08-17
Valid Till : 2023-06-22
Written Confirmation Number : WC-0404
Address of the Firm : Plot No.40/A Sy.13,15,16,51,52 &182 J.N Pharma City Thanam village Parawada mand...
Date of Issue : 2019-10-07
Valid Till : 2022-07-02
Written Confirmation Number : WC-0226
Address of the Firm : D-24 and D24/1 MIDC Kurkumbh Tal. Daund, Dist Pune 413 802, Maharashtra State
Date of Issue : 2020-04-15
Valid Till : 2023-05-19
Written Confirmation Number : WC-0281new2
Address of the Firm : Sy. No. 224/A, Bibinagar(V) & (M), Bhongir, Nalgonda District, Andhra Pradesh
Date of Issue : 2018-01-01
Valid Till : 2020-05-19
Written Confirmation Number : WC-0281A3
Address of the Firm : Sy. No. 224/A, Bibinagar(V) & (M), Bhongir, Nalgonda District, Andhra Pradesh
Date of Issue : 2019-07-15
Valid Till : 2022-07-14
Written Confirmation Number : WC-0042
Address of the Firm : Plot No.262, 263, IDA, Pashamylaram, Medak District, A.P
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|
Upgrade, download data, analyse, strategize, subscribe with us
Biophore is a research-driven global pharmaceutical company focused on niche APIs for the generic industry.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-07-03
Application Number : 211076
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SYPRINE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 1985-11-08
Application Number : 19194
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : CLOVIQUE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-10-21
Application Number : 209731
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2020-05-21
Application Number : 211637
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-01-16
Application Number : 211251
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablets
Dosage Strength : 250mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Regulatory Info :
Registration Country : Italy
Brand Name : CUFENCE
Dosage Form : Hard Capsule Oral Use Bottle
Dosage Strength : 200 mg
Packaging : 100 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Canada
Brand Name : WAYMADE-TRIENTINE
Dosage Form : CAPSULE
Dosage Strength : 250MG
Packaging :
Approval Date :
Application Number : 2515067
Regulatory Info :
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : TRIENTINE HYDROCHLORIDE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 250MG
Packaging :
Approval Date : 2019-09-25
Application Number : 210096
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Turkey
Brand Name : SIPRYNE
Dosage Form : Capsule
Dosage Strength : 250MG
Packaging : 100 Capsules / Bottle
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Turkey
Regulatory Info :
Registration Country : Italy
Brand Name : CUFENCE
Dosage Form : Hard Capsule Oral Use Bottle
Dosage Strength : 200 mg
Packaging : 100 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Italy
Brand Name : TRIENTINA WAYMADE
Dosage Form : Hard Capsules
Dosage Strength : 200 mg
Packaging : 100 UNITS 200 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info :
Registration Country : Switzerland
Brand Name : Triogen
Dosage Form : Caps
Dosage Strength : 250mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Regulatory Info :
Registration Country : Switzerland
Brand Name : Wilentin
Dosage Form : Caps
Dosage Strength : 250mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Switzerland
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
A Trientine Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Trientine Hydrochloride, including repackagers and relabelers. The FDA regulates Trientine Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Trientine Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Trientine Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Trientine Hydrochloride supplier is an individual or a company that provides Trientine Hydrochloride active pharmaceutical ingredient (API) or Trientine Hydrochloride finished formulations upon request. The Trientine Hydrochloride suppliers may include Trientine Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Trientine Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Trientine Hydrochloride DMF (Drug Master File) is a document detailing the whole manufacturing process of Trientine Hydrochloride active pharmaceutical ingredient (API) in detail. Different forms of Trientine Hydrochloride DMFs exist exist since differing nations have different regulations, such as Trientine Hydrochloride USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Trientine Hydrochloride DMF submitted to regulatory agencies in the US is known as a USDMF. Trientine Hydrochloride USDMF includes data on Trientine Hydrochloride's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Trientine Hydrochloride USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Trientine Hydrochloride suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Trientine Hydrochloride Drug Master File in Japan (Trientine Hydrochloride JDMF) empowers Trientine Hydrochloride API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Trientine Hydrochloride JDMF during the approval evaluation for pharmaceutical products. At the time of Trientine Hydrochloride JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Trientine Hydrochloride suppliers with JDMF on PharmaCompass.
A Trientine Hydrochloride written confirmation (Trientine Hydrochloride WC) is an official document issued by a regulatory agency to a Trientine Hydrochloride manufacturer, verifying that the manufacturing facility of a Trientine Hydrochloride active pharmaceutical ingredient (API) adheres to the Good Manufacturing Practices (GMP) regulations of the importing country. When exporting Trientine Hydrochloride APIs or Trientine Hydrochloride finished pharmaceutical products to another nation, regulatory agencies frequently require a Trientine Hydrochloride WC (written confirmation) as part of the regulatory process.
click here to find a list of Trientine Hydrochloride suppliers with Written Confirmation (WC) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Trientine Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Trientine Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Trientine Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Trientine Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Trientine Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Trientine Hydrochloride suppliers with NDC on PharmaCompass.
Trientine Hydrochloride Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Trientine Hydrochloride GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Trientine Hydrochloride GMP manufacturer or Trientine Hydrochloride GMP API supplier for your needs.
A Trientine Hydrochloride CoA (Certificate of Analysis) is a formal document that attests to Trientine Hydrochloride's compliance with Trientine Hydrochloride specifications and serves as a tool for batch-level quality control.
Trientine Hydrochloride CoA mostly includes findings from lab analyses of a specific batch. For each Trientine Hydrochloride CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Trientine Hydrochloride may be tested according to a variety of international standards, such as European Pharmacopoeia (Trientine Hydrochloride EP), Trientine Hydrochloride JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Trientine Hydrochloride USP).
LOOKING FOR A SUPPLIER?